Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emily, Wichern"'
Autor:
William L. Shelton, Peter C. Krause, Rabun Fox, Mallory Lowe, Laura DeLatin, Claudia Leonardi, Anna N. Miller, Clay Spitler, Brian Mullis, Jonathan Savakus, Kevin Purcell, Justin Tilan, Heather Vallier, Emily Wichern
Publikováno v:
The Journal of Foot and Ankle Surgery. 62:50-54
The purpose of this multicenter retrospective chart review was to describe demographics, fracture and wound characteristics, and treatments for foot and/or ankle fractures caused by gunshot wounds (GSWs) and identify factors that increase risk of inf
Publikováno v:
The Journal of Arthroplasty. 35:2983-2995
Background This study quantified the effectiveness of contemporary and evidence-based standardized 2-stage treatment for periprosthetic hip infection. Findings illustrate potential limitations of criticisms of 2-stage protocols and potential conseque
Autor:
James A. Hamilton, Paul Childress, Amber L. Mosley, Nickolay Brustovetsky, Jagannath Misra, Keith R. Stayrook, Joseph M. Wallace, Angela Klunk, Ronald C. Wek, Joseph P. Bidwell, Yu Shao, Michele Adaway, Alexander G. Robling, David B. Burr, Deepak Vashishth, Kylie Jacobs, Yunlong Liu, Matthew R. Allen, Emily Wichern
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 316:E749-E772
A goal of osteoporosis therapy is to restore lost bone with structurally sound tissue. Mice lacking the transcription factor nuclear matrix protein 4 ( Nmp4, Zfp384, Ciz, ZNF384) respond to several classes of osteoporosis drugs with enhanced bone for
Autor:
Yu, Shao, Emily, Wichern, Paul J, Childress, Michele, Adaway, Jagannath, Misra, Angela, Klunk, David B, Burr, Ronald C, Wek, Amber L, Mosley, Yunlong, Liu, Alexander G, Robling, Nickolay, Brustovetsky, James, Hamilton, Kylie, Jacobs, Deepak, Vashishth, Keith R, Stayrook, Matthew R, Allen, Joseph M, Wallace, Joseph P, Bidwell
Publikováno v:
Am J Physiol Endocrinol Metab
A goal of osteoporosis therapy is to restore lost bone with structurally sound tissue. Mice lacking the transcription factor nuclear matrix protein 4 (Nmp4, Zfp384, Ciz, ZNF384) respond to several classes of osteoporosis drugs with enhanced bone form